Luke A. Wittenburg

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma

Rebecca Barnard, Luke A. Wittenburg, Ravi K. Amaravadi et al. · Autophagy · 2014 · 163 citations · Full text

Medicine, Oncology, Pharmacology +16

Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.

Lisa R. Bartner, Stephanie McGrath, Sangeeta Rao et al. · PubMed · 2018 · 130 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9

The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin

Luke A. Wittenburg, Liam Bisson, Barbara Rose et al. · Cancer Chemotherapy and Pharmacology · 2010 · 64 citations

Medicine, Oncology, Pharmacology +14

An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats

Sarah Cook, Luke A. Wittenburg, Victoria C. Yan et al. · Viruses · 2022 · 41 citations · Full text

Veterinary Medicine, Infectious Diseases, Veterinary Pharmacology +16

Phase I Pharmacokinetic and Pharmacodynamic Evaluation of Combined Valproic Acid/Doxorubicin Treatment in Dogs with Spontaneous Cancer

Luke A. Wittenburg, Daniel L. Gustafson, Douglas H. Thamm · Clinical Cancer Research · 2010 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17